Valuation: Enovis Corporation

Market Cap 150.98Cr 129.33Cr 121.01Cr 110.77Cr 207.88Cr 14TCr 210.63Cr 1.43TCr 557.53Cr 7.26TCr 566.91Cr 554.58Cr 24TCr P/E 2026 *
89.9x
P/E 2027 * 24.2x
Enterprise Value 272.45Cr 233.38Cr 218.37Cr 199.89Cr 375.14Cr 26TCr 380.1Cr 2.58TCr 1.01TCr 13TCr 1.02TCr 1TCr 43TCr EV / Sales 2026 *
1.16x
EV / Sales 2027 * 1.06x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-0.46%
1 week+1.56%
Current month-10.60%
1 month-2.91%
3 months-1.51%
6 months+14.65%
Current year-2.18%
1 week 24.5
Extreme 24.5
27.46
1 month 23.62
Extreme 23.625
31.66
Current year 19.14
Extreme 19.14
31.66
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

846 0.0015%
31/03/26 Free

Director

770 0.0013%
07/03/26 Free

Chief Executive Officer

1,43,923 0.2518%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%+1.56%-13.13%-52.64% 150.98Cr
+0.53%-3.41%-15.93%+18.55% 13TCr
-0.37%-3.26%-23.11%0.00% 1.23TCr
0.00%-2.41%+103.31%+157.51% 1.09TCr
-4.90%-10.62%-51.00%-69.98% 435.24Cr
-0.43%-2.30%-24.71%+48.21% 269.84Cr
+1.78%+7.15%-32.98%-71.19% 177.13Cr
-1.13%-1.74%-23.13%-13.10% 168.02Cr
-3.68%-3.69%-35.84%-36.66% 166.91Cr
Average -0.96%-1.21%-12.95%-2.15% 1.81TCr
Weighted average by Cap. +0.21%-3.55%-10.00%+22.05%

Financials

2026 *2027 *
Net sales 234.03Cr 200.47Cr 187.58Cr 171.7Cr 322.24Cr 22TCr 326.5Cr 2.22TCr 864.23Cr 11TCr 878.76Cr 859.64Cr 37TCr 245.47Cr 210.27Cr 196.74Cr 180.09Cr 337.99Cr 23TCr 342.45Cr 2.32TCr 906.46Cr 12TCr 921.71Cr 901.65Cr 39TCr
Net income 1.15Cr 98.51L 92.17L 84.37L 1.58Cr 110.03Cr 1.6Cr 11Cr 4.25Cr 55Cr 4.32Cr 4.22Cr 182.82Cr 6.08Cr 5.21Cr 4.88Cr 4.46Cr 8.38Cr 582.21Cr 8.49Cr 58Cr 22Cr 292.47Cr 23Cr 22Cr 967.37Cr
Net Debt 121.47Cr 104.05Cr 97Cr 89Cr 167.26Cr 12TCr 169.47Cr 1.15TCr 448.58Cr 5.84TCr 456.12Cr 446.2Cr 19TCr 108.48Cr 93Cr 87Cr 80Cr 149.37Cr 10TCr 151.34Cr 1.03TCr 400.6Cr 5.21TCr 407.34Cr 398.48Cr 17TCr
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
21/26/21 $26.06 -0.46% 6,10,995
20/26/20 $26.18 -1.21% 6,57,560
19/26/19 $26.50 +3.35% 7,48,363
18/26/18 $25.64 +3.64% 8,07,503
17/26/17 $24.74 -5.07% 10,89,524
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
26.06USD
Average target price
40.83USD
Spread / Average Target
+56.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock